HIGHFDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride Tablets 50 mg 100-count Recall 2025

Zydus Lifesciences and Northstar Rx LLC recall Chlorpromazine Hydrochloride Tablets, 50 mg, 100-count bottles distributed nationwide in the United States. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above the acceptable intake limit. Stop using the product immediately and contact your healthcare provider or Zydus Pharmaceuticals (USA) Inc for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 3, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brands
Zydus Lifesciences, Northstar Rx LLC
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Zydus Lifesciences, Northstar Rx LLC
Product type
Chlorpromazine Hydrochloride Tablets 50 mg
Model numbers
Z306326, Z401155
UPC codes
16714-047, 16714-048, 16714-049, 16714-050, 16714-051, 16714-047-01, 16714-048-01, 16714-049-01 +2 more
Sizes
50 mg, 100-count
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 3, 2025

  2. Reported by FDA DRUG

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A

About This Product

Chlorpromazine hydrochloride is a prescription antipsychotic used to treat certain mental disorders. This recall involves a 50 mg, 100-count bottle intended for Rx use.

Why This Is Dangerous

The recall cites CGMP deviations resulting in the impurity N-Nitroso Desmethyl Chlorpromazine exceeding acceptable intake limits.

Industry Context

This recall is not described as part of a broader industry pattern in the provided information.

Real-World Impact

Exposure to the impurity could pose long-term health risks. There are no reported injuries or incidents yet. Consumers should stop use and seek guidance from a healthcare provider.

Practical Guidance

How to identify if yours is affected

  1. Locate the bottle label for 'Chlorpromazine Hydrochloride Tablets, 50 mg, 100-count'
  2. Check the NDC 16714-049-01 on the label
  3. Confirm manufacturer as Zydus Lifesciences and distributor Northstar Rx LLC

Where to find product info

NDC on the bottle label and packaging; recall page on FDA site

What timeline to expect

Refunds or replacements will be determined by the manufacturer; monitor updates from FDA and company communications (no specific timeframe provided)

If the manufacturer is unresponsive

  • File a complaint with FDA MedWatch if adverse events occur or recall communications are slow
  • Consult your pharmacist or healthcare provider for alternatives and guidance

How to prevent similar issues

  • Purchase medications only from licensed pharmacies
  • Verify NDC and packaging before use
  • Keep recall notices and packaging for reference
  • Ask for pharmacist guidance when switching to alternatives

Documentation advice

Retain the bottle, packaging, recall notification, and any communications with the manufacturer or healthcare provider

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: Z306326; Z401155 Where sold: Nationwide in the USA When sold: N/A Price: N/A

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 16714-049-01 NDC on product label
  • 50 mg strength per tablet
  • Manufactured by Zydus Lifesciences Ltd. (India)
  • Distributed nationwide in the USA by Northstar Rx LLC
  • Model numbers Z306326 and Z401155

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONINGOTHER

Product Details

Model Numbers
Z306326
Z401155
UPC Codes
16714-047
16714-048
16714-049
+7 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls